Burning Rock Biotech Limited (NASDAQ:BNR) traded at $24.01 at last check on Friday, Nov 20, making a downturn move of -7.4% on its previous day’s price.
Looking at the stock we see that its previous close was $25.93 and the beta (5Y monthly) reads 0 with the day’s price range being $23.30 – 26.46. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, BNR has a high of $32.4 and a low of $18.64. The company’s stock has gained about -17.04% over that past 30 days.
Based on estimates by 1 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, none have rated the Burning Rock Biotech Limited (BNR) stock as a Hold, while 1 rate it as a Buy. None analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Let’s briefly compare Burning (BNR) stock to its peers. We find that today’s price change of -7.4% and 0% over the past 12 months for BNR competes that of Spotify Technology S.A. (SPOT), which has seen its stock price rise 4.02% in the latest trading session and is +86.97% over the last one year. Another of its peers Docusign Inc (DOCU) has climbed 0.86% today, and is +216.83% up over the past year, while Thomson Reuters Corp (TRI) is also down -7.4% yet its price remains in the red at 0% over the same period. Spotify has a P/E ratio of 0 compared to Burning’s 0 and Docusign’s 0. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to Burning Rock Biotech Limited (NASDAQ:BNR), we note that the average 3-month trading volume was 133.89 Million, while that of the preceding 10-day period stands at 100.35 Million. Current shares outstanding are 101.78 Million.
According to data from Thomson Reuters, insiders hold 0% of the company’s shares while institutions hold 19.31%. The data shows that short shares as of October 29, 2020, stood at 334.31 Million at a short ratio of 2.33. This represents a 0.33% Short interest in Shares outstanding on October 29, 2020. Shares short rose in October from the previous month at 224.51 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -2.52% down in year-to-date price movement.